Clinical Trial Update: A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer [Phase 2]

View source ↗

Summary

Roche is conducting a Phase 2 study to evaluate inavolisib in participants with early-stage, PIK3CA-mutated breast cancer; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Inavolisib (Inavolisib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING